Clinical Scorecard: Infections at Surgical Sites

At a Glance

Key Highlights

• SSIs are the third most common nosocomial infection and leading cause of hospital admissions related to infections.
• Risk factors for SSIs are multifactorial, including patient, procedural, and environmental factors; laparoscopic surgery reduces SSI risk.
• Antimicrobial prophylaxis is indicated primarily in clean-contaminated and contaminated surgeries, with timing and antibiotic choice guided by procedure and microbial flora.

Guideline-Based Recommendations

Diagnosis

• Identify SSIs by clinical signs such as purulent drainage, erythema, swelling, warmth, fever >38°C, wound dehiscence, or abscess detected clinically or radiologically.
• Use clinical severity scoring systems like the ASEPSIS score to assess infection severity and guide management.

Management

• Administer surgical antimicrobial prophylaxis intravenously within 30–60 minutes before incision (60–120 minutes for vancomycin or fluoroquinolones).
• Select prophylactic antibiotics based on surgical site microbial flora, local resistance patterns, and guidelines.
• Intraoperative antibiotic redosing if surgery duration exceeds two half-lives of the antibiotic or significant blood loss occurs.
• Implement evidence-based perioperative preventive measures to reduce SSI incidence.

Monitoring & Follow-up

• Conduct surveillance programs to ensure appropriate antibiotic use and adherence to guidelines.
• Regularly assess antibiotic prescribing practices, effectiveness, and impact on local antimicrobial resistance.
• Provide continuous monitoring and feedback to optimize antibiotic use and minimize resistance development.

Risks

• Excessive or inappropriate antibiotic use increases risk of adverse drug reactions, Clostridium difficile infection, and antimicrobial resistance.
• Higher NNIS risk index scores correlate with increased SSI risk.
• Obesity may require weight-based antibiotic dosing adjustments, though evidence on dose escalation benefits is limited.

Patient & Prescribing Data

Patients undergoing clean-contaminated, contaminated, or clean surgeries with additional risk factors.

IV antibiotic prophylaxis is preferred for rapid therapeutic levels; timing and choice depend on procedure and microbial flora; dose adjustments considered for obesity; prophylaxis not indicated for dirty surgeries where therapy is therapeutic.

Clinical Best Practices

• Strict adherence to perioperative preventive measures tailored to patient and procedural risk factors.
• Use of validated risk indices (e.g., NNIS) preoperatively to estimate SSI risk and guide prophylaxis.
• Timely administration of prophylactic antibiotics with appropriate selection based on surgical site and microbial ecology.
• Implementation of hospital surveillance programs to monitor antibiotic use and resistance patterns.
• Utilization of clinical severity scores (e.g., ASEPSIS) for SSI assessment and management decisions.

References

• CDC and NHSN definition of SSI
• ECDC point prevalence survey on healthcare-associated infections
• NNIS risk index and SSI risk estimation
• ECDC annual epidemiological report on SSIs
• Guidelines for antimicrobial prophylaxis in surgery
• ASEPSIS scoring system for SSI severity